================================================================================
TRAIN SPLIT â€” 20 samples (20 positive, 0 negative)
================================================================================

--- Sample 1 ---

PROMPT:
Generate Cypher to store medical relations from text: Naloxone reverses the antihypertensive effect of clonidine. In unanesthetized, spontaneously hypertensive rats the decrease in blood pressure and heart rate produced by intravenous clonidine, 5 to 20 micrograms/kg, was inhibited or reversed by nalozone, 0.2 to 2 mg/kg. The hypotensive effect of 100 mg/kg alpha-methyldopa was also partially reversed by naloxone. Naloxone alone did not affect either blood pressure or heart rate. In brain membranes from spontaneously hypertensive rats clonidine, 10(-8) to 10(-
Cypher:

TARGET:
MERGE (h:Chemical {name: 'alpha-methyldopa'}) MERGE (t:Disease {name: 'hypotensive'}) MERGE (h)-[:INDUCES]->(t)

GRAPH EDGES:
  (:Chemical) alpha-methyldopa  --[:INDUCES]-->  (:Disease) hypotensive

--- Sample 2 ---

PROMPT:
Generate Cypher to store medical relations from text: Lidocaine-induced cardiac asystole. Intravenous administration of a single 50-mg bolus of lidocaine in a 67-year-old man resulted in profound depression of the activity of the sinoatrial and atrioventricular nodal pacemakers. The patient had no apparent associated conditions which might have predisposed him to the development of bradyarrhythmias; and, thus, this probably represented a true idiosyncrasy to lidocaine.
Cypher:

TARGET:
MERGE (h:Chemical {name: 'Lidocaine'}) MERGE (t:Disease {name: 'cardiac asystole'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'lidocaine'}) MERGE (t:Disease {name: 'cardiac asystole'}) MERGE (h)-[:INDUCES]->(t)

GRAPH EDGES:
  (:Chemical) Lidocaine  --[:INDUCES]-->  (:Disease) cardiac asystole
  (:Chemical) lidocaine  --[:INDUCES]-->  (:Disease) cardiac asystole

--- Sample 3 ---

PROMPT:
Generate Cypher to store medical relations from text: Suxamethonium infusion rate and observed fasciculations. A dose-response study. Suxamethonium chloride (Sch) was administered i.v. to 36 adult males at six rates: 0.25 mg s-1 to 20 mg s-1. The infusion was discontinued either when there was no muscular response to tetanic stimulation of the ulnar nerve or when Sch 120 mg was exceeded. Six additional patients received a 30-mg i.v. bolus dose. Fasciculations in six areas of the body were scored from 0 to 3 and summated as a total fasciculation score. The time
Cypher:

TARGET:
MERGE (h:Chemical {name: 'Suxamethonium'}) MERGE (t:Disease {name: 'fasciculations'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Suxamethonium'}) MERGE (t:Disease {name: 'Fasciculations'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Suxamethonium'}) MERGE (t:Disease {name: 'fasciculation'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Suxamethonium chloride'}) MERGE (t:Disease {name: 'fasciculations'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Suxamethonium chloride'}) MERGE (t:Disease {name: 'Fasciculations'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Suxamethonium chloride'}) MERGE (t:Disease {name: 'fasciculation'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Sch'}) MERGE (t:Disease {name: 'fasciculations'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Sch'}) MERGE (t:Disease {name: 'Fasciculations'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Sch'}) MERGE (t:Disease {name: 'fasciculation'}) MERGE (h)-[:INDUCES]->(t)

GRAPH EDGES:
  (:Chemical) Suxamethonium  --[:INDUCES]-->  (:Disease) fasciculations
  (:Chemical) Suxamethonium  --[:INDUCES]-->  (:Disease) Fasciculations
  (:Chemical) Suxamethonium  --[:INDUCES]-->  (:Disease) fasciculation
  (:Chemical) Suxamethonium chloride  --[:INDUCES]-->  (:Disease) fasciculations
  (:Chemical) Suxamethonium chloride  --[:INDUCES]-->  (:Disease) Fasciculations
  (:Chemical) Suxamethonium chloride  --[:INDUCES]-->  (:Disease) fasciculation
  (:Chemical) Sch  --[:INDUCES]-->  (:Disease) fasciculations
  (:Chemical) Sch  --[:INDUCES]-->  (:Disease) Fasciculations
  (:Chemical) Sch  --[:INDUCES]-->  (:Disease) fasciculation

--- Sample 4 ---

PROMPT:
Generate Cypher to store medical relations from text: Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of the central effects of scopolamine (Hyoscine). Galanthamine hydrobromide, an anticholinesterase drug capable of penetrating the blood-brain barrier, was used in a patient demonstrating central effects of scopolamine (hyoscine) overdosage. It is longer acting than physostigmine and is used in anaesthesia to reverse the non-depolarizing neuromuscular block. However, studies into the dose necessary to combating scopolamine 
Cypher:

TARGET:
MERGE (h:Chemical {name: 'scopolamine'}) MERGE (t:Disease {name: 'overdosage'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Hyoscine'}) MERGE (t:Disease {name: 'overdosage'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'hyoscine'}) MERGE (t:Disease {name: 'overdosage'}) MERGE (h)-[:INDUCES]->(t)

GRAPH EDGES:
  (:Chemical) scopolamine  --[:INDUCES]-->  (:Disease) overdosage
  (:Chemical) Hyoscine  --[:INDUCES]-->  (:Disease) overdosage
  (:Chemical) hyoscine  --[:INDUCES]-->  (:Disease) overdosage

--- Sample 5 ---

PROMPT:
Generate Cypher to store medical relations from text: Effects of uninephrectomy and high protein feeding on lithium-induced chronic renal failure in rats. Rats with lithium-induced nephropathy were subjected to high protein (HP) feeding, uninephrectomy (NX) or a combination of these, in an attempt to induce glomerular hyperfiltration and further progression of renal failure. Newborn female Wistar rats were fed a lithium-containing diet (50 mmol/kg) for 8 weeks and then randomized to normal diet, HP diet (40 vs. 19%), NX or HP+NX for another 8 weeks. Correspond
Cypher:

TARGET:
MERGE (h:Chemical {name: 'lithium'}) MERGE (t:Disease {name: 'hypertension'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Li'}) MERGE (t:Disease {name: 'hypertension'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Lithium'}) MERGE (t:Disease {name: 'hypertension'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'lithium'}) MERGE (t:Disease {name: 'proteinuria'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Li'}) MERGE (t:Disease {name: 'proteinuria'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Lithium'}) MERGE (t:Disease {name: 'proteinuria'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'lithium'}) MERGE (t:Disease {name: 'chronic renal failure'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Li'}) MERGE (t:Disease {name: 'chronic renal failure'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Lithium'}) MERGE (t:Disease {name: 'chronic renal failure'}) MERGE (h)-[:INDUCES]->(t)

GRAPH EDGES:
  (:Chemical) lithium  --[:INDUCES]-->  (:Disease) hypertension
  (:Chemical) Li  --[:INDUCES]-->  (:Disease) hypertension
  (:Chemical) Lithium  --[:INDUCES]-->  (:Disease) hypertension
  (:Chemical) lithium  --[:INDUCES]-->  (:Disease) proteinuria
  (:Chemical) Li  --[:INDUCES]-->  (:Disease) proteinuria
  (:Chemical) Lithium  --[:INDUCES]-->  (:Disease) proteinuria
  (:Chemical) lithium  --[:INDUCES]-->  (:Disease) chronic renal failure
  (:Chemical) Li  --[:INDUCES]-->  (:Disease) chronic renal failure
  (:Chemical) Lithium  --[:INDUCES]-->  (:Disease) chronic renal failure

--- Sample 6 ---

PROMPT:
Generate Cypher to store medical relations from text: Treatment of Crohn's disease with fusidic acid: an antibiotic with immunosuppressive properties similar to cyclosporin. Fusidic acid is an antibiotic with T-cell specific immunosuppressive effects similar to those of cyclosporin. Because of the need for the development of new treatments for Crohn's disease, a pilot study was undertaken to estimate the pharmacodynamics and tolerability of fusidic acid treatment in chronic active, therapy-resistant patients. Eight Crohn's disease patients were included. Fusid
Cypher:

TARGET:
MERGE (h:Chemical {name: 'fusidic acid'}) MERGE (t:Disease {name: 'nausea'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Fusidic acid'}) MERGE (t:Disease {name: 'nausea'}) MERGE (h)-[:INDUCES]->(t)

GRAPH EDGES:
  (:Chemical) fusidic acid  --[:INDUCES]-->  (:Disease) nausea
  (:Chemical) Fusidic acid  --[:INDUCES]-->  (:Disease) nausea

--- Sample 7 ---

PROMPT:
Generate Cypher to store medical relations from text: Electrocardiographic evidence of myocardial injury in psychiatrically hospitalized cocaine abusers. The electrocardiograms (ECG) of 99 cocaine-abusing patients were compared with the ECGs of 50 schizophrenic controls. Eleven of the cocaine abusers and none of the controls had ECG evidence of significant myocardial injury defined as myocardial infarction, ischemia, and bundle branch block.
Cypher:

TARGET:
MERGE (h:Chemical {name: 'cocaine'}) MERGE (t:Disease {name: 'myocardial infarction'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'cocaine'}) MERGE (t:Disease {name: 'bundle branch block'}) MERGE (h)-[:INDUCES]->(t)

GRAPH EDGES:
  (:Chemical) cocaine  --[:INDUCES]-->  (:Disease) myocardial infarction
  (:Chemical) cocaine  --[:INDUCES]-->  (:Disease) bundle branch block

--- Sample 8 ---

PROMPT:
Generate Cypher to store medical relations from text: Sulpiride-induced tardive dystonia. Sulpiride is a selective D2-receptor antagonist with antipsychotic and antidepressant properties. Although initially thought to be free of extrapyramidal side effects, sulpiride-induced tardive dyskinesia and parkinsonism have been reported occasionally. We studied a 37-year-old man who developed persistent segmental dystonia within 2 months after starting sulpiride therapy. We could not find any previous reports of sulpiride-induced tardive dystonia.
Cypher:

TARGET:
MERGE (h:Chemical {name: 'Sulpiride'}) MERGE (t:Disease {name: 'tardive dystonia'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Sulpiride'}) MERGE (t:Disease {name: 'dystonia'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'sulpiride'}) MERGE (t:Disease {name: 'tardive dystonia'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'sulpiride'}) MERGE (t:Disease {name: 'dystonia'}) MERGE (h)-[:INDUCES]->(t)

GRAPH EDGES:
  (:Chemical) Sulpiride  --[:INDUCES]-->  (:Disease) tardive dystonia
  (:Chemical) Sulpiride  --[:INDUCES]-->  (:Disease) dystonia
  (:Chemical) sulpiride  --[:INDUCES]-->  (:Disease) tardive dystonia
  (:Chemical) sulpiride  --[:INDUCES]-->  (:Disease) dystonia

--- Sample 9 ---

PROMPT:
Generate Cypher to store medical relations from text: Ocular and auditory toxicity in hemodialyzed patients receiving desferrioxamine. During an 18-month period of study 41 hemodialyzed patients receiving desferrioxamine (10-40 mg/kg BW/3 times weekly) for the first time were monitored for detection of audiovisual toxicity. 6 patients presented clinical symptoms of visual or auditory toxicity. Moreover, detailed ophthalmologic and audiologic studies disclosed abnormalities in 7 more asymptomatic patients. Visual toxicity was of retinal origin and was character
Cypher:

TARGET:
MERGE (h:Chemical {name: 'desferrioxamine'}) MERGE (t:Disease {name: 'pigmentary retinal deposits'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Desferrioxamine'}) MERGE (t:Disease {name: 'pigmentary retinal deposits'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'desferrioxamine'}) MERGE (t:Disease {name: 'Ocular toxicity'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'desferrioxamine'}) MERGE (t:Disease {name: 'visual toxicity'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'desferrioxamine'}) MERGE (t:Disease {name: 'Visual toxicity'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'desferrioxamine'}) MERGE (t:Disease {name: 'a loss of visual acuity'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Desferrioxamine'}) MERGE (t:Disease {name: 'Ocular toxicity'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Desferrioxamine'}) MERGE (t:Disease {name: 'visual toxicity'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Desferrioxamine'}) MERGE (t:Disease {name: 'Visual toxicity'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Desferrioxamine'}) MERGE (t:Disease {name: 'a loss of visual acuity'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'desferrioxamine'}) MERGE (t:Disease {name: 'neurosensorial hearing loss'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'Desferrioxamine'}) MERGE (t:Disease {name: 'neurosensorial hearing loss'}) MERGE (h)-[:INDUCES]->(t)

GRAPH EDGES:
  (:Chemical) desferrioxamine  --[:INDUCES]-->  (:Disease) pigmentary retinal deposits
  (:Chemical) Desferrioxamine  --[:INDUCES]-->  (:Disease) pigmentary retinal deposits
  (:Chemical) desferrioxamine  --[:INDUCES]-->  (:Disease) Ocular toxicity
  (:Chemical) desferrioxamine  --[:INDUCES]-->  (:Disease) visual toxicity
  (:Chemical) desferrioxamine  --[:INDUCES]-->  (:Disease) Visual toxicity
  (:Chemical) desferrioxamine  --[:INDUCES]-->  (:Disease) a loss of visual acuity
  (:Chemical) Desferrioxamine  --[:INDUCES]-->  (:Disease) Ocular toxicity
  (:Chemical) Desferrioxamine  --[:INDUCES]-->  (:Disease) visual toxicity
  (:Chemical) Desferrioxamine  --[:INDUCES]-->  (:Disease) Visual toxicity
  (:Chemical) Desferrioxamine  --[:INDUCES]-->  (:Disease) a loss of visual acuity
  (:Chemical) desferrioxamine  --[:INDUCES]-->  (:Disease) neurosensorial hearing loss
  (:Chemical) Desferrioxamine  --[:INDUCES]-->  (:Disease) neurosensorial hearing loss

--- Sample 10 ---

PROMPT:
Generate Cypher to store medical relations from text: Myasthenia gravis presenting as weakness after magnesium administration. We studied a patient with no prior history of neuromuscular disease who became virtually quadriplegic after parenteral magnesium administration for preeclampsia. The serum magnesium concentration was 3.0 mEq/L, which is usually well tolerated. The magnesium was stopped and she recovered over a few days. While she was weak, 2-Hz repetitive stimulation revealed a decrement without significant facilitation at rapid rates or after exercise
Cypher:

TARGET:
MERGE (h:Chemical {name: 'magnesium'}) MERGE (t:Disease {name: 'Myasthenia gravis'}) MERGE (h)-[:INDUCES]->(t)
MERGE (h:Chemical {name: 'magnesium'}) MERGE (t:Disease {name: 'myasthenia gravis'}) MERGE (h)-[:INDUCES]->(t)

GRAPH EDGES:
  (:Chemical) magnesium  --[:INDUCES]-->  (:Disease) Myasthenia gravis
  (:Chemical) magnesium  --[:INDUCES]-->  (:Disease) myasthenia gravis

